Phathom Pharmaceuticals(PHAT) - 2025 Q4 - Annual Results

Financial Results Announcement - Phathom Pharmaceuticals, Inc. announced preliminary unaudited financial results for Q4 and full year 2025 on January 7, 2026[4]. - A press release detailing the financial results is attached as Exhibit 99.1[6]. - The financial results include key metrics that will be elaborated in the press release[4]. Compliance and Listing Information - The company is listed on The Nasdaq Global Select Market under the symbol PHAT[2]. - The report is filed under the SEC regulations, indicating compliance with the Securities Exchange Act of 1934[5].